Related Experiment Video
Updated: Mar 25, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Modified Sleep Apnea Severity Index and Cardiovascular Risk in CPAP-Intolerant OSA Patients
Praneet C Kaki1, Jennifer A Goldfarb1, Melissa Xu1
1Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Objective:
The modified sleep apnea severity index (mSASI) combines patient anatomy, weight, sleep study metrics, and symptoms into a composite OSA index ranging from 1 (least severe) to 3 (most severe). Our study aims to assess the association between the mSASI and cardiovascular (CV) risk factors in patients undergoing sleep surgery.
Study Design:
Retrospective cohort review.
Setting:
Single-institution tertiary care center.
Methods:
CPAP-intolerant OSA patients who underwent hypoglossal nerve stimulation, maxillomandibular advancement, or expansion sphincter pharyngoplasty at our institution from 2014 to 2021 were included. Cardiovascular comorbidities and 5-year Framingham Risk Score (FRS) were assessed at the preoperative visit. Chi-squared and Wilcoxon rank sum test analyses were performed using R Studio.
Results:
Of the 209 patients included, 118 had an mSASI = 1, 71 had an mSASI = 2, and 20 had an mSASI = 3. Patients with an mSASI of 2 or 3 were more likely to have HTN (33% vs 51%, p = 0.011). Baseline mSASI (β = 4.4, 95% CI 0.04-8.7) and age (β = 1.3, 95% CI 1.0-1.6) were independently associated with increased FRS on multivariable linear regression (p < 0.05). However, this association did not persist in secondary models excluding constituent components of mSASI and FRS.
Conclusions:
The mSASI may offer additional benefits in assessing OSA risk severity based on CV risk factors compared to the AHI alone. However, given that this association was not replicated in the secondary analysis, further research is needed to evaluate the utility beyond its individual factors and traditional metrics alone.
Insights
The modified sleep apnea severity index (mSASI) shows potential in assessing cardiovascular risk in sleep apnea patients. However, further research is needed to confirm its utility beyond individual components.
Area of Science:
- Sleep Medicine
- Cardiology
- Otolaryngology
Background:
- Obstructive Sleep Apnea (OSA) is linked to increased cardiovascular (CV) risk.
- The modified sleep apnea severity index (mSASI) is a composite score integrating patient anatomy, weight, sleep study metrics, and symptoms.
- Assessing the association between mSASI and CV risk factors is crucial for patient management.
Purpose of the Study:
- To evaluate the relationship between the mSASI and cardiovascular risk factors in patients undergoing surgical treatment for OSA.
- To determine if mSASI provides additional predictive value for CV risk beyond traditional metrics.
Main Methods:
- Retrospective cohort review of 209 CPAP-intolerant OSA patients who underwent surgery.
- Assessment of cardiovascular comorbidities and 5-year Framingham Risk Score (FRS) preoperatively.
- Statistical analyses including Chi-squared and Wilcoxon rank sum tests, and multivariable linear regression.
Main Results:
- Patients with higher mSASI scores (2 or 3) were more likely to have hypertension (p=0.011).
- Baseline mSASI and age were independently associated with increased FRS on multivariable analysis (p<0.05).
- This association did not persist in secondary analyses excluding constituent components of mSASI and FRS.
Conclusions:
- The mSASI may offer supplementary value in evaluating OSA severity concerning CV risk factors compared to Apnea-Hypopnea Index (AHI) alone.
- Further investigation is required to validate the mSASI's utility beyond its constituent factors and established metrics.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Hyperpnea and Hyperventilation
Mechanical Ventilation I: Indication and Settings
Measurement of Blood Pressure
Cardiopulmonary Resuscitation II: ACLS Airway Management

